CCP
CLLS

Clough Capital Partners’s Cellectis CLLS Stock Holding History

Clough Capital Partners’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-153,350
Closed -$3.69M – 174
2016
Q3 		$3.69M Sell
153,350
-18,200
-11% -$476K 0.19% 111
2016
Q2 		$4.56M Buy
171,550
+10,600
+7% +$311K 0.24% 109
2016
Q1 		$4.43M Sell
160,950
-47,150
-23% -$1.14M 0.21% 112
2015
Q4 		$6.46M Buy
+208,100
New +$6.31M 0.3% 97

Other funds holding CLLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Clough Capital Partners's CLLS Position: Q4 2016 in Review

Clough Capital Partners sold out of Cellectis (CLLS) in Q4 2016, closing a stake of 153,350 shares — an estimated $3.69M sold.

Clough Capital Partners first reported a position in CLLS in Q4 2015 and held it in 4 quarters. The position peaked at $6.46M in Q4 2015. 37 funds tracked by Wall St. Rank hold CLLS as of Q4 2016.

  • Clough Capital Partners reported no remaining Cellectis position as of Q4 2016 after selling out during the quarter.
  • Clough Capital Partners sold 153,350 Cellectis shares in Q4 2016, an estimated $3.69M.
  • Clough Capital Partners first reported a position in Cellectis in Q4 2015 and held it in 4 quarters.
  • Clough Capital Partners's Cellectis position peaked at $6.46M in Q4 2015.
  • 37 funds tracked by Wall St. Rank held Cellectis as of Q4 2016.

Based on Clough Capital Partners's 13F filing for Q4 2016, filed 14 Feb 2017.